Theriva Biologics
Stock Forecast, Prediction & Price Target
Theriva Biologics Financial Estimates
Theriva Biologics Revenue Estimates
Theriva Biologics EBITDA Estimates
Theriva Biologics Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $29.37M Low: $29.37M High: $29.37M avg. 0% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $25.72M Low: $25.72M High: $25.72M avg. 0% |
Net Income
% change YoY
| $-14.17M N/A | $-19.68M -38.88% | $-18.34M 6.78% | Avg: $-34.28M Low: $-12.24M High: $-12.24M avg. -86.86% | Avg: $-37.12M Low: $-10.79M High: $-10.79M avg. -8.28% | Avg: $-11.59M Low: $-11.59M High: $-11.59M avg. 68.76% | Avg: $-7.40M Low: $-7.40M High: $-7.40M avg. 36.11% |
EBITDA
% change YoY
| $-14.27M N/A | $-21.45M -50.30% | $-19.85M 7.46% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$1.16 N/A | -$1.28 -10.34% | -$28.49 -2125.78% | Avg: -$0.76 Low: -$0.76 High: -$0.76 avg. 97.33% | Avg: -$0.67 Low: -$0.67 High: -$0.67 avg. 11.84% | Avg: -$0.72 Low: -$0.72 High: -$0.72 avg. -7.46% | Avg: -$0.46 Low: -$0.46 High: -$0.46 avg. 36.11% |
Operating Expenses
% change YoY
| $14.27M N/A | $21.58M 51.19% | $21.43M -0.69% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Theriva Biologics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 2.43% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -12.24M, average is -34.28M and high is -12.24M.
What is Theriva Biologics stock revenue growth forecast?
We have gathered data from 1 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Theriva Biologics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 34.45% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$0.76, average is -$0.76 and high is $-0.76.